Development
PROCEPT BioRobotics Corporation
PRCT
$62.91
-$2.14-3.29%
NASDAQ
| 12/31/2023 | 09/30/2023 | ||||
|---|---|---|---|---|---|
| Revenue | 24.16% | 6.04% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 24.16% | 6.04% | |||
| Cost of Revenue | 37.58% | 10.58% | |||
| Gross Profit | 12.62% | 2.41% | |||
| SG&A Expenses | 10.44% | 1.36% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 20.47% | 3.37% | |||
| Operating Income | -15.42% | 0.06% | |||
| Income Before Tax | -11.70% | 2.62% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -11.70% | 2.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -11.70% | 2.62% | |||
| EBIT | -15.42% | 0.06% | |||
| EBITDA | -15.00% | 1.71% | |||
| EPS Basic | -6.67% | 8.97% | |||
| Normalized Basic EPS | -6.69% | 8.97% | |||
| EPS Diluted | -6.67% | 8.97% | |||
| Normalized Diluted EPS | -6.69% | 8.97% | |||
| Average Basic Shares Outstanding | 4.72% | 6.98% | |||
| Average Diluted Shares Outstanding | 4.72% | 6.98% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||